Abstract

Increasing the dose intensity of chemotherapy for newly diagnosed diffuse large B-cell lymphoma (DLBCL) has been proposed as a means to improve

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call